This abstracts session presents contemporary research and clinical insights in interventional cardiology, covering topics such as colchicine therapy post-stenting, ranolazine use in chronic coronary syndrome, artificial intelligence applications in quantitative coronary analysis, and optimization techniques in transcatheter aortic valve implantation. It also explores novel predictors of...

A 60-year-old male with hypertension, type II diabetes, and moderately impaired LV function (45%), has a history of LAD PCI treated with three Cypher stents in 2006. He underwent further treatment for LAD in-stent restenosis in 2012, 2020, and 2022 using a new stent and DCB....

This session addresses the complexities of PCI in post-CABG patients, focusing on the application of intravascular imaging and functional assessment to guide strategy. It discusses clinical and anatomical factors influencing the choice between native vessel and graft PCI, and explores management techniques for unyielding graft lesions,...

This session presents a comprehensive exploration of vascular interventions, highlighting advanced techniques such as retrograde tibial artery approaches for long CTO lesions in the superficial femoral artery, catheter-directed thrombectomy for bilateral pulmonary embolism, and innovative endovascular management of pulmonary haemorrhages in Eisenmenger syndrome. Case reports and...

Explore the management of heavily calcified LAD lesions in this PCRGulf-GIM 2025 session. Discover how OCT imaging guides lesion assessment, differentiates superficial from deep calcium, and informs the need for plaque modification. Learn when and how to use orbital atherectomy or intravascular lithotripsy, and follow the...

This session examines complex bifurcation interventions, addressing challenging cases such as isolated Medina 0,0,1 left main bifurcation and imaging-guided trifurcation angioplasty in acute coronary syndromes. It emphasizes strategic approaches and device selection to overcome anatomical complexities, manage complications, and achieve successful outcomes in bifurcation PCI.

Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...

In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.